Fintel reports that on February 14, 2025, Evercore ISI Group upgraded their outlook for CRISPR Therapeutics (NasdaqGM:CRSP) from In-Line to Outperform. Analyst Price Forecast Suggests 90.46% Upside As ...

The expansion of private credit and increased private equity hold times have led to a surge in creative solutions to get capital back to investors.

With an ever-growing list of similar-sounding funds to choose from, finding the best is an increasingly difficult task.

PDI, a closed-end fund managed by PIMCO, offers a robust 13.5% dividend yield and is well-positioned for the coming rate ...

The International Energy Agency (IEA) says in a new report, that “global electricity use is forecast to rise significantly in the coming years ...

While noting that further measures to revive the exchange have yet to be announced, Citi analyst Tan Yong Hong in a Feb 13 ...

We recently published a list of 10 Best Major Stocks to Buy According to Hedge Funds. In this article, we are going to take a ...

A hedge fund startup that uses artificial intelligence to do work typically handled by analysts has outperformed the global ...

We recently published a list of 10 Best Major Stocks to Buy According to Hedge Funds. In this article, we are going to take a ...

Marietta City Council held meetings for the Finance, Water, Sewer and Sanitation, Planning, Zoning, Annexation and Housing ...

Dimensional Fund Advisors' latest research adds to existing literature highlighting sometimes-overlooked downsides with the ongoing rush to low-cost ETFs and other products.

The mechanics of a PM deal are complex. Contracts are increasingly nuanced and bespoke, including caveats and clawbacks.